London, UK. March 30th
OptiGene today launches Novus, a next-generation molecular diagnostics platform that moves testing out of the lab and into the real-time moments where decisions have to be made.
For decades, molecular diagnostics have delivered precision. But too often, that precision has arrived too late to influence real-world outcomes and decisions, with a complicated test workflow due to complex liquid handling and sample preparation processes.
Novus changes that.
Built on OptiGene’s proven science, Novus delivers a rapid, one-step, on-site detection of DNA and RNA, enabling users to identify disease presence before it becomes visible, and act earlier, with greater confidence.
A shift from delayed results to real-time insight and on-site decisions.
Results without the laboratory
Novus reflects a clear direction of travel to provide error free, real-time, on-site diagnostics capability.
In today’s rapidly changing environment, timing becomes everything.
Novus delivers results without the laboratory, bringing reliable molecular diagnostics to the point of need and removing the delays that slow decisions down.
No more complexity. Calmer decisions.
“This is about changing when decisions get made”
Ross Haffenden, COO at OptiGene, said:
“Novus is a natural progression for us, but it’s also a step change in how molecular diagnostics are used.
The industry doesn’t need more data for the sake of it. It needs clarity, earlier.
What we’re doing with Novus is moving trusted science closer to the point of decision, so people can act before problems escalate, not after.
That’s where the real value sits. Better timing. Calmer decisions.”
A new standard for real-world diagnostics
The launch of Novus signals a shift in expectation.
Diagnostics should not sit in the background. They should actively shape outcomes.
As pressure grows across agriculture, animal health, food security, food authenticity, and bio security to improve efficiency, reduce waste, and respond to increasingly unpredictable conditions, Novus is built to support a more proactive, data-led approach.
For more information: Click here
